0001493152-20-009960.txt : 20200527
0001493152-20-009960.hdr.sgml : 20200527
20200527180543
ACCESSION NUMBER: 0001493152-20-009960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200522
FILED AS OF DATE: 20200527
DATE AS OF CHANGE: 20200527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sinha Shishir K.
CENTRAL INDEX KEY: 0001812640
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 20916468
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: SUITE B
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090402
4
1
ownership.xml
X0306
4
2020-05-22
0
0001460702
Qualigen Therapeutics, Inc.
QLGN
0001812640
Sinha Shishir K.
C/O QUALIGEN THERAPEUTICS, INC.,
2042 CORTE DEL NOGAL
CARLSBAD
CA
92011
0
1
0
0
Vice President of Operations
Warrant (Right to Buy)
2.0663
2020-05-22
4
J
0
8857
A
2020-05-22
2024-01-31
Common Stock
8857
8857
D
Warrant (Right to Buy)
2.0663
2020-05-22
4
J
0
26570
A
2020-05-22
2024-08-20
Common Stock
26570
26570
D
On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer.
Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer.
/s/ Hayden Trubitt, Attorney-in-Fact for Shishir K. Sinha
2020-05-27